REGN

748.87

2.47% -18.98

시간 외 거래: 749.36 0.49 +0.07%

리제네론 파마슈티컬스 (REGN)

개요 뉴스 가격 이력 옵션 체인 Financials REGN 왜 하락? 토론 예측

전일 마감가:

$767.85

열려 있는:

$771.48

하루 거래량:

751.19K

Relative Volume:

1.01

시가총액:

$79.17B

수익:

$14.34B

순이익/손실:

$4.50B

주가수익비율:

18.02

EPS:

41.5626

순현금흐름:

$3.77B

1주 성능:

-1.70%

1개월 성능:

-3.00%

6개월 성능:

+32.63%

1년 성능:

+37.06%

1일 변동 폭

$739.09

$771.48

1주일 범위

$739.09

$775.62

52주 변동 폭

$476.49

$821.11

리제네론 파마슈티컬스 Stock (REGN) Company Profile

명칭

Regeneron Pharmaceuticals Inc

부문

Healthcare (1106)

산업

Biotechnology (623)

전화

(914) 847-7000

주소

777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY

직원

15,410

트위터

@regeneron

다음 수익 날짜

2026-01-30

최신 SEC 제출 서류

REGN's Discussions on Twitter

Compare REGN vs VRTX, ARGX, ALNY, ONC

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
REGN Regeneron Pharmaceuticals Inc	748.87	81.18B	14.34B	4.50B	3.77B	41.56
VRTX Vertex Pharmaceuticals Inc	436.27	113.64B	12.07B	3.95B	3.19B	15.33
ARGX Argen X Se Adr	799.65	49.78B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	322.11	42.87B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	309.66	34.79B	5.36B	287.73M	924.18M	2.5229

리제네론 파마슈티컬스 Stock (REGN) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-03-31	재개	Piper Sandler	Overweight
2026-03-06	개시	Barclays	Overweight
2026-01-07	업그레이드	BofA Securities	Underperform → Buy
2025-12-03	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2025-11-24	개시	HSBC Securities	Buy
2025-11-24	재개	Truist	Buy
2025-11-13	개시	Scotiabank	Sector Perform
2025-08-14	개시	Rothschild & Co Redburn	Buy
2025-06-30	다운그레이드	Argus	Buy → Hold
2025-05-30	다운그레이드	RBC Capital Mkts	Outperform → Sector Perform
2025-05-30	다운그레이드	Wells Fargo	Overweight → Equal Weight
2025-05-14	업그레이드	Citigroup	Neutral → Buy
2025-04-22	재개	Cantor Fitzgerald	Overweight
2025-02-05	업그레이드	Leerink Partners	Market Perform → Outperform
2025-01-16	다운그레이드	UBS	Buy → Neutral
2024-12-10	재개	BofA Securities	Underperform
2024-11-15	개시	Wolfe Research	Outperform
2024-11-14	개시	Citigroup	Neutral
2024-09-24	다운그레이드	Leerink Partners	Outperform → Market Perform
2024-03-12	개시	Bernstein	Outperform
2024-01-12	업그레이드	RBC Capital Mkts	Sector Perform → Outperform
2023-11-09	개시	Deutsche Bank	Hold
2023-11-03	업그레이드	Raymond James	Mkt Perform → Outperform
2023-08-21	업그레이드	Canaccord Genuity	Hold → Buy
2023-08-21	재확인	Oppenheimer	Perform
2023-06-28	다운그레이드	Canaccord Genuity	Buy → Hold
2023-03-27	업그레이드	SVB Securities	Market Perform → Outperform
2023-03-24	업그레이드	Jefferies	Hold → Buy
2023-03-23	업그레이드	Raymond James	Underperform → Mkt Perform
2023-01-30	업그레이드	Cowen	Market Perform → Outperform
2023-01-20	업그레이드	JP Morgan	Neutral → Overweight
2022-10-26	다운그레이드	Raymond James	Mkt Perform → Underperform
2022-10-17	다운그레이드	Evercore ISI	Outperform → In-line
2022-09-09	업그레이드	Jefferies	Underperform → Hold
2022-09-09	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2022-07-25	다운그레이드	SVB Leerink	Outperform → Mkt Perform
2022-07-13	개시	Cantor Fitzgerald	Neutral
2022-06-06	개시	Jefferies	Underperform
2022-05-23	개시	SVB Leerink	Outperform
2022-01-05	다운그레이드	BofA Securities	Neutral → Underperform
2022-01-03	업그레이드	Bernstein	Mkt Perform → Outperform
2021-12-15	다운그레이드	Bernstein	Outperform → Mkt Perform
2021-12-09	재개	Wells Fargo	Overweight
2021-12-07	재개	Cowen	Market Perform
2021-12-06	개시	Goldman	Buy
2021-11-19	재개	BMO Capital Markets	Outperform
2021-11-05	다운그레이드	The Benchmark Company	Buy → Hold
2021-06-29	개시	H.C. Wainwright	Buy
2021-01-25	업그레이드	BMO Capital Markets	Market Perform → Outperform
2021-01-13	업그레이드	The Benchmark Company	Hold → Buy
2021-01-08	업그레이드	Citigroup	Neutral → Buy
2020-10-05	업그레이드	Cantor Fitzgerald	Neutral → Overweight
2020-08-20	다운그레이드	The Benchmark Company	Buy → Hold
2020-07-09	업그레이드	SunTrust	Hold → Buy
2020-05-26	업그레이드	Wells Fargo	Equal Weight → Overweight
2020-04-28	다운그레이드	Citigroup	Buy → Neutral
2020-04-17	업그레이드	The Benchmark Company	Hold → Buy
2020-04-08	개시	The Benchmark Company	Hold
2020-03-31	개시	Wolfe Research	Peer Perform
2020-02-27	개시	Barclays	Overweight
2020-02-26	업그레이드	Canaccord Genuity	Hold → Buy
2020-02-26	다운그레이드	Robert W. Baird	Outperform → Neutral
2020-02-25	업그레이드	Jefferies	Hold → Buy
2020-02-11	업그레이드	Argus	Hold → Buy
2019-12-24	개시	Raymond James	Mkt Perform
2019-12-16	다운그레이드	Evercore ISI	Outperform → In-line
2019-12-13	업그레이드	Credit Suisse	Neutral → Outperform
2019-11-12	개시	SunTrust	Hold
2019-11-07	업그레이드	Citigroup	Neutral → Buy
2019-10-17	재개	BofA/Merrill	Neutral
2019-09-23	업그레이드	Guggenheim	Neutral → Buy

모두보기

리제네론 파마슈티컬스 주식(REGN)의 최신 뉴스

11:16 AM

Should FDA Approval of Extended EYLEA HD Dosing Flexibility Require Action From Regeneron Pharmaceuticals (REGN) Investors? - Yahoo Finance

11:16 AM

03:18 AM

Regeneron Pharmaceuticals, Inc. $REGN Stake Raised by Bar Harbor Wealth Management - MarketBeat

03:18 AM

01:21 AM

Regeneron Pharmaceuticals (NASDAQ:REGN) Downgraded to Hold Rating by Wall Street Zen - MarketBeat

01:21 AM

Apr 10, 2026

Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch

Apr 10, 2026

Today's Analyst Rating Update for Regeneron Pharmaceuticals (REG - GuruFocus

Apr 10, 2026

Morgan Stanley Issues Positive Forecast for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price - MarketBeat

Apr 10, 2026

Piper Sandler reiterates Overweight rating on Regeneron stock at $875 - Investing.com

Apr 10, 2026

Regeneron Pharmaceuticals Inc stock: What you should know now - AD HOC NEWS

Apr 10, 2026

Intratumoral Cancer Therapies Market: Expanding Revenue Landscape to 2034 – DelveInsight | Amgen, Daiichi Sankyo, AiViva BioPharma, Lytix Biopharma, Regeneron Pharma, Checkmate Pharma, Replimune - Barchart.com

Apr 10, 2026

Intratumoral Cancer Therapies Market: Expanding Revenue - openPR.com

Apr 10, 2026

DDD Partners LLC Raises Stock Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Apr 10, 2026

Atopic Dermatitis (7MM) Drug Market Forecast and Analysis Report 2023-2033: Opportunities Remain for the Treatment of AD, Novel Systemic Therapies Dominate the Late-stage Pipeline - GlobeNewswire Inc.

Apr 10, 2026

Regeneron (REGN): Buy, Sell, or Hold Post Q4 Earnings? - The Globe and Mail

Apr 10, 2026

Apr 09, 2026

Aug Final Week: Does Regeneron Pharmaceuticals Inc have pricing power2026 Buyback Activity & Technical Pattern Based Buy Signals - baoquankhu1.vn

Apr 09, 2026

OFI Invest Asset Management Buys Regeneron Pharmaceuticals Shares - National Today

Apr 09, 2026

OFI Invest Asset Management Buys Shares of 31,265 Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Apr 09, 2026

Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Cache Advisors LLC - MarketBeat

Apr 09, 2026

Apr 08, 2026

Regeneron (REGN) Faces $102M Charge Impacting Q1 2026 Earnings - GuruFocus

Apr 08, 2026

Regeneron Pharmaceuticals Inc. stock rises Wednesday, still underperforms market - MarketWatch

Apr 08, 2026

Analyst Lowers Price Target for REGN, Maintains Outperform Ratin - GuruFocus

Apr 08, 2026

Sanford C. Bernstein Has Lowered Expectations for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price - MarketBeat

Apr 08, 2026

Bernstein SocGen lowers Regeneron stock price target on revenue mix shift - Investing.com Australia

Apr 08, 2026

COPD Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Genentech, GlaxoSmithKline, Verona Pharma, Regeneron Pharma, Sanofi, MedImmune, EpiEndo Pharma, Tetherex Pharma, AstraZene - Barchart.com

Apr 08, 2026

Regeneron Pharmaceuticals, Inc. Form 8-K Filing Details for April 8, 2026 – Company Info, Stock, and Compliance 2324 - Minichart

Apr 08, 2026

Regeneron expects $102 million IPR&D charge to impact Q1 2026 earnings - Investing.com Australia

Apr 08, 2026

Raymond James reiterates Outperform on Regeneron stock on Eylea HD growth - Investing.com

Apr 08, 2026

Asio Capital LLC Makes New $3.42 Million Investment in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Apr 08, 2026

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives Consensus Rating of "Moderate Buy" from Analysts - marketbeat.com

Apr 08, 2026

Apr 07, 2026

Avoiding Lag: Real-Time Signals in (REGN) Movement - Stock Traders Daily

Apr 07, 2026

RBC Capital Maintains Regeneron Pharmaceuticals(REGN.US) With Hold Rating, Raises Target Price to $779 - Moomoo

Apr 07, 2026

Eosinophilic Esophagitis Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Regeneron Pharma, Sanofi, Bristol-Myers Squibb, Ellodi Pharma, AstraZeneca, Allakos, EsoCap, Pfizer - Barchart.com

Apr 07, 2026

RBC Adjusts Price Target on Regeneron Pharmaceuticals to $779 From $765, Maintains Sector Perform Rating - Moomoo

Apr 07, 2026

Monoclonal Antibody Therapeutics (Mabs) Market (2026-2033) | - openPR.com

Apr 07, 2026

Here’s what analysts are saying about Regeneron Pharmaceuticals (REGN) - MSN

Apr 07, 2026

Assessing Regeneron Pharmaceuticals (REGN) Valuation After FDA Approval Extends EYLEA HD Dosing Intervals - simplywall.st

Apr 07, 2026

Apr 06, 2026

Regeneron And TriNetX Partner To Expand Global Genomic And EHR Linked Data Platform - BioPharma APAC

Apr 06, 2026

Surprises Report: What are the future prospects of Regeneron Pharmaceuticals IncWeekly Market Outlook & Smart Swing Trading Techniques - baoquankhu1.vn

Apr 06, 2026

Targets Report: Is Regeneron Pharmaceuticals Inc gaining market shareQuarterly Earnings Summary & Weekly Chart Analysis and Guides - baoquankhu1.vn

Apr 06, 2026

Regeneron Wins FDA Nod for Extended Eylea HD Dosing Interval - finance.yahoo.com

Apr 06, 2026

FDA approves expanded EYLEA HD dosing intervals - Eyes On Eyecare

Apr 06, 2026

All You Need to Know About Regeneron (REGN) Rating Upgrade to Buy - Yahoo Finance

Apr 06, 2026

Apr 05, 2026

Tritonpoint Wealth LLC Sells 1,938 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Apr 05, 2026

Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Sovran Advisors LLC - MarketBeat

Apr 05, 2026

2,145 Shares in Regeneron Pharmaceuticals, Inc. $REGN Acquired by Perpetual Ltd - MarketBeat

Apr 05, 2026

Apr 04, 2026

Regeneron’s EYLEA HD Label Update Shifts Retinal Care And Competition - simplywall.st

Apr 04, 2026

Regeneron Pharma (REGN) shares up after Jim Cramer called it a good stock - MSN

Apr 04, 2026

REGN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 04, 2026

Regeneron Pharmaceuticals Inc (REGN) SEC filings - GuruFocus

Apr 04, 2026

Regeneron Pharmaceuticals Inc (REGN) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus

Apr 04, 2026

Allspring Global Investments Boosts Stake in Regeneron Pharmaceuticals - National Today

Apr 04, 2026

Regeneron Pharmaceuticals, Inc. $REGN Shares Bought by Allspring Global Investments Holdings LLC - MarketBeat

Apr 04, 2026